AIM ImmunoTech Inc.

NYSEAM:AIM Stock Report

Market Cap: US$12.4m

AIM ImmunoTech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NYSEAM:AIM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Dec 24SellUS$884William MitchellIndividual4,580US$0.19
18 Dec 24BuyUS$4,682Thomas EquelsIndividual22,727US$0.21
02 Dec 24BuyUS$2,356Stewart AppelrouthIndividual11,112US$0.21
20 Nov 24BuyUS$16,915Thomas EquelsIndividual85,000US$0.20
20 Nov 24BuyUS$11,000Thomas EquelsIndividual60,110US$0.18
20 Nov 24BuyUS$15,817Stewart AppelrouthIndividual81,953US$0.19
16 Sep 24BuyUS$1,515Thomas EquelsIndividual5,000US$0.30
13 Sep 24BuyUS$6,160Thomas EquelsIndividual20,000US$0.31
06 May 24BuyUS$12,500Peter RodinoIndividual30,865US$0.41
06 May 24BuyUS$25,000Thomas EquelsIndividual61,729US$0.41
21 Mar 24BuyUS$15,000Nancy BryanIndividual38,462US$0.39
15 Mar 24BuyUS$30,000Stewart AppelrouthIndividual90,910US$0.33
15 Mar 24BuyUS$25,000Thomas EquelsIndividual75,758US$0.33
15 Mar 24BuyUS$12,500Peter RodinoIndividual37,879US$0.33

Insider Trading Volume

Insider Buying: AIM insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of AIM?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,682,6177.34%
Individual Insiders5,887,0409.23%
General Public53,209,66883.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 30.6%.

Top Shareholders

Top 25 shareholders own 16.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.12%
The Vanguard Group, Inc.
1,988,704US$387.8k0%no data
2.69%
Todd Deutsch
1,716,100US$334.6k0%no data
2.64%
Thomas Equels
1,680,695US$327.7k12.6%no data
2.34%
Ted Kellner
1,493,000US$291.1k0%no data
1.09%
BlackRock, Inc.
698,267US$136.2k0%no data
0.73%
Geode Capital Management, LLC
464,016US$90.5k15.7%no data
0.72%
Citadel Advisors LLC
457,767US$89.3k367%no data
0.63%
Peter Rodino
401,262US$78.2k88.8%no data
0.6%
Stewart Appelrouth
379,961US$74.1k58.5%no data
0.38%
Renaissance Technologies LLC
243,208US$47.4k6.29%no data
0.27%
State Street Global Advisors, Inc.
173,103US$33.8k0%no data
0.24%
Verition Fund Management LLC
153,000US$29.8k0%no data
0.19%
William Mitchell
123,803US$24.1k62%no data
0.16%
Virtu Financial LLC, Asset Management Arm
102,129US$19.9k81.7%no data
0.13%
Nancy Bryan
85,559US$16.7k122%no data
0.13%
Northern Trust Global Investments
85,119US$16.6k0%no data
0.13%
Morgan Stanley, Investment Banking and Brokerage Investments
84,320US$16.4k-1.17%no data
0.1%
XTX Holdings Limited, Asset Management Arm
65,897US$12.8k354%no data
0.055%
SeaCrest Wealth Management, LLC
35,063US$6.8k0%no data
0.054%
Hudson River Trading LLC, Asset Management Arm
34,744US$6.8k0%no data
0.031%
CapFinancial Partners, LLC, Asset Management Arm
20,000US$3.9k0%no data
0.024%
Tower Research Capital Europe Limited
15,261US$3.0k-42.9%no data
0.021%
Nottingham Advisors Inc.
13,226US$2.6k0%no data
0.019%
D.B. Root & Company, LLC
12,050US$2.3k0%no data
0.018%
Traynor Capital Management, Inc.
11,777US$2.3k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:36
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AIM ImmunoTech Inc. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Ling WangChardan Capital Markets, LLC
Jason McCarthyMaxim Group